Literature DB >> 31772737

Upper limb motor improvement in chronic stroke after combining botulinum toxin A injection and multi-joints robot-assisted therapy: a case report.

Alex Martino Cinnera1, Alessandra Pucello1, Alessandro Lupo2, Francesca Gimigliano3, Elisa Mammucari1, Dario Lo Cicero1, Marco Iosa1, Stefano Paolucci1, Giovanni Morone1.   

Abstract

Spasticity is one of the major complications after stroke. Botulinum toxin type A (BoNT-A) injection is commonly used to manage focal spasticity. However, it is uncertain whether BoNT-A can improve activities of daily living function of paretic arm. The recovery of functions of the affected arm is also the aim of robotic upper limb (UL) therapy. The motorized exoskeleton assists the patient in a large 3D work environment by promoting movement for the UL (shoulder, elbow, wrist, hand). The combination of the BoNT-A injection and the robotic therapy might enhance functional recovery after stroke. We reported the case of a chronic stroke patient in which the injection of BoNT-A was combined with multi-joint exoskeleton training. The patient showed improvement in the motor control of the UL, supporting the feasibility of this approach.
© The Author(s) 2019. Published by Oxford University Press.

Entities:  

Keywords:  botulinum toxins type A; exoskeleton device; hemiplegia; stroke; upper extremity

Year:  2019        PMID: 31772737      PMCID: PMC6822606          DOI: 10.1093/omcr/omz097

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


  15 in total

Review 1.  Xeomin: an innovative new botulinum toxin type A.

Authors:  J Frevert
Journal:  Eur J Neurol       Date:  2009-12       Impact factor: 6.089

2.  Functional outcome measures in stroke rehabilitation.

Authors:  F Vanclay
Journal:  Stroke       Date:  1991-01       Impact factor: 7.914

3.  Effects of robot-assisted gait training in chronic stroke patients treated by botulinum toxin-a: A pivotal study.

Authors:  Dursun Erbil; Gokbel Tugba; Topcu Hasan Murat; Akarsu Melike; Akyüz Merve; Karacan Cagla; Çiftçi Can Mehmetali; Öztürk Akay; Dursun Nigar
Journal:  Physiother Res Int       Date:  2018-05-28

Review 4.  Rehabilitative devices for a top-down approach.

Authors:  Giovanni Morone; Grazia Fernanda Spitoni; Daniela De Bartolo; Sheida Ghanbari Ghooshchy; Fulvia Di Iulio; Stefano Paolucci; Pierluigi Zoccolotti; Marco Iosa
Journal:  Expert Rev Med Devices       Date:  2019-02-06       Impact factor: 3.166

Review 5.  Poststroke spasticity management.

Authors:  Gerard E Francisco; John R McGuire
Journal:  Stroke       Date:  2012-09-13       Impact factor: 7.914

6.  Direct central action of intramuscularly injected botulinum toxin: is it harmful or beneficial?

Authors:  Ryuji Kaji
Journal:  J Physiol       Date:  2013-02-15       Impact factor: 5.182

7.  Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.

Authors:  Kazuya Saita; Takashi Morishita; Koichi Hyakutake; Hiroyuki Fukuda; Etsuji Shiota; Yoshiyuki Sankai; Tooru Inoue
Journal:  J Neurol Sci       Date:  2016-12-28       Impact factor: 3.181

8.  Early development of spasticity following stroke: a prospective, observational trial.

Authors:  Jörg Wissel; Ludwig D Schelosky; Jeffrey Scott; Walter Christe; Jürgen H Faiss; Jörg Mueller
Journal:  J Neurol       Date:  2010-02-06       Impact factor: 4.849

9.  Rehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized Trial.

Authors:  Deidre Devier; JoAnn Harnar; Leandro Lopez; Allison Brashear; Glenn Graham
Journal:  Toxins (Basel)       Date:  2017-07-11       Impact factor: 4.546

10.  Effectiveness of Robot-Assisted Upper Limb Training on Spasticity, Function and Muscle Activity in Chronic Stroke Patients Treated With Botulinum Toxin: A Randomized Single-Blinded Controlled Trial.

Authors:  Marialuisa Gandolfi; Nicola Valè; Eleonora Kirilova Dimitrova; Stefano Mazzoleni; Elena Battini; Mirko Filippetti; Alessandro Picelli; Andrea Santamato; Michele Gravina; Leopold Saltuari; Nicola Smania
Journal:  Front Neurol       Date:  2019-01-31       Impact factor: 4.003

View more
  1 in total

1.  Botulinum Toxin Type A Possibly Affects Cav3.2 Calcium Channel Subunit in Rats with Spinal Cord Injury-Induced Muscle Spasticity.

Authors:  Kening Ma; Dan Zhu; Chunguo Zhang; Lijie Lv
Journal:  Drug Des Devel Ther       Date:  2020-07-28       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.